Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2545 of 6351
-
Teen diabetes study seeks to uncover hidden triggers of kidney damage
Knowledge-focused Recruiting nowThe overall aim of the project is to elucidate the primary bio-psycho-social (BPS) risk factors for albuminuria in youth with type 2 diabetes (T2D) and the mechanisms by which they cause renal injury. The Study aims include: 1. Characterize the primary BPS risk factors associate…
Sponsor: University of Manitoba • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could a Cell-Cycle protein reveal how aggressive oral cancer is?
Knowledge-focused CompletedOral squamous cell carcinoma is a major public health problem , especially in West Asian countries. Cyclin D1 accelerates cell cycle and thus may be implicated in uncontrolled cellular proliferation and tumor progression.
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can a cheaper plastic knee implant match the metal one in older adults?
Disease control PausedTotal knee arthroplasty (TKA) is one of the most commonly performed orthopaedic procedures. Approximately 84,000 knee replacement procedures were recorded in the UK in 2012. The main goal of TKA is to relieve the disabling pain of arthritic disease. Patient satisfaction followin…
Sponsor: Maidstone & Tunbridge Wells NHS Trust • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a leukemia drug slow Alzheimer's? small study tests safety
Disease control CompletedThe investigators hypothesize that Nilotinib will be safe in individuals with mild to moderate AD. Specifically, investigators hypothesize that low daily oral doses of Nilotinib will lead to CSF penetration, CNS Abl inhibition, and stabilization of CSF total Tau and p-Tau231/181 …
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New cocktail of drugs shows promise for tough prostate cancer
Disease control CompletedThis is a multi-center, Phase I study of apalutamide in combination with abiraterone acetate, docetaxel and prednisone in patients with metastatic mastrate resistant prostate cancer (mCRPC). This study is designed to determine the dose that apalutamide can be administered safely…
Phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New urine test could spare bladder cancer patients from painful scopes
Diagnosis Recruiting nowVoided urinary cytology (VUC) is the most widely used urine-based assay for detecting bladder cancer (BCa); however, it fails to detect approximately 50% of low-grade or early stage BCa when it is most curable. Furthermore, the detection rate of VUC for recurrent BCa is not much …
Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Prostate cancer drug enzalutamide tested for Long-Term safety in ongoing study
Disease control OngoingThe purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) whic…
Phase 2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Virtual Check-Ups after ER visits could help kids with asthma breathe easier
Disease control CompletedIn the US, children from minority ethnic and racial backgrounds suffer disproportionately from asthma and account for substantially more emergency department (ED) visits and hospitalizations than non-minority children. While NHLBI guidelines recommend daily preventive medications…
Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis is a safety, efficacy, and pharmacokinetics (PK) study of vibostolimab (MK-7684) as monotherapy and in combination with pembrolizumab (MK-3475) or pembrolizumab plus pemetrexed and carboplatin in adults with metastatic solid tumors for which there is no available therapy tha…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Massive study aims to unlock secrets of rare inflammatory diseases
Knowledge-focused Recruiting nowBackground: Some diseases cause chronic inflammation with intermittent flares in the body. These are called autoinflammatory diseases. They can cause fevers, rashes, ulcers, and other problems. Researchers want to learn more about the causes and effects of these diseases. They h…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New hope for metastatic breast cancer: pill combo may replace chemo
Disease control OngoingThis is an open-label, pilot study designed to evaluate the safety and feasibility of combining anastrozole and palbociclib in the following two cohorts: Cohort A) as first-line therapy and Cohort B) as maintenance therapy after first-line chemotherapy in postmenopausal patients …
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Genetic test could shorten hospital stays for fungal infection patients
Knowledge-focused CancelledMonocentric study with the objective to evaluate the impact of genotyping CYP2C19 on the hospitalization period. The genotyping will permit to adapt at best the Voriconazole posology.
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Oxygen therapy shows promise for aging brains and bodies
Disease control CompletedRecent studies show preliminary evidence of HBOT therapeutic effects on angiogenesis, increased tissue blood flow and oxygenation correlated with tissue function. Our primary hypothesis is that HBOT will have beneficial effects on the above mentioned organs associated with aging…
Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart drug metoprolol may shield patients from Post-Surgery heart injury
Disease control CompletedThe purpose of this research study is to test if a commonly used, FDA-approved medication, called metoprolol, given at the conclusion of anesthesia following surgery, and during postoperative admission, reduces the possibility of heart related complications in patients with coron…
Phase 3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immunotherapy combo shows promise for rare cancers, but study halted early
Disease control Stopped earlyThis is an investigator initiated single institution, open-label study to evaluate the antitumor activity, safety, and tolerability of durvalumab in combination with tremelimumab in subjects with select advanced rare solid tumors.
Phase 2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a tiny heart pump Fine-Tune support for failing hearts?
Knowledge-focused CompletedProspective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Scientists hunt for clues in body fluids to predict liver failure outcomes
Knowledge-focused OngoingAcute liver injury (ALI) and acute liver failure (ALF) are rare clinical conditions, the latter often associated with a poor outcome. To improve outcomes for these patients, clinicians need to develop a clearer understanding of the pathophysiology of this condition. Biomarkers an…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New balloon treatment shows promise for leg artery blockages
Disease control CompletedThis clinical study is a prospective, non-randomized, multicenter study to demonstrate the acceptable safety and performance of angioplasty with the Ranger DCB in native femoropopliteal artery lesions. It is intended that all patients with qualifying lesions would be considered f…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can exercise coaching keep seniors safe from falls?
Prevention CompletedThe investigators propose a 36-month multi-center randomized effectiveness trial to compare the impact of an Enhanced Usual Care (Control) intervention, with Exercise Coaching (Exercise), on Serious Fall-Related Injuries (SFI) in patients with a previous fragility fracture (FF). …
Sponsor: Milton S. Hershey Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Massive gene hunt launched to unlock Alzheimer's secrets
Knowledge-focused Recruiting nowThe goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history o…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC